Aquarian to acquire Brighthouse Financial (NASDAQ: BHF) in $4.1B cash deal
Brighthouse Financial, Inc. reported fourth quarter and full-year 2025 results and highlighted progress on its pending sale to Aquarian Capital. Fourth quarter 2025 net income available to shareholders was $112 million, or $1.93 per diluted share, down from $646 million, or $10.79, a year earlier. Adjusted earnings were $214 million, or $3.70 per diluted share, and adjusted earnings, less notable items, were $227 million, or $3.93, versus $352 million, or $5.88, in the prior-year quarter.
For full year 2025, net income available to shareholders was $331 million, or $5.71 per diluted share, compared with $286 million, or $4.64, in 2024. Full-year adjusted earnings, less notable items, were $931 million, or $16.07 per diluted share, down from $1,209 million, or $19.63, in 2024. The company ended 2025 with book value of $5.1 billion, or $88.66 per common share, and book value excluding AOCI of $8.8 billion, or $153.89 per share.
Capital and sales metrics remained strong. Brighthouse cited a preliminary combined risk-based capital ratio of 456%, above its 400%–450% target range in normal markets, and holding company liquid assets of $0.9 billion. Full-year annuity sales were $10.3 billion, up 3% year-over-year, driven by record Shield Level Annuities, while life sales reached a record $143 million, up 19%.
The company also detailed segment performance. In the fourth quarter, Annuities delivered adjusted earnings of $304 million, flat sequentially and up from $279 million a year earlier. Life adjusted earnings were $18 million, down from $52 million in the prior-year quarter, reflecting lower underwriting margin, lower net investment income, higher expenses and a $6 million unfavorable notable item. The Run-off segment recorded an adjusted loss of $58 million, widening from a $27 million loss a year ago, and Corporate & Other posted an adjusted loss of $50 million, compared with break-even results in the prior-year quarter.
Investment results remained sizeable. Fourth quarter net investment income was $1,328 million, with adjusted net investment income of $1,334 million and an adjusted net investment income yield of 4.44%. The company’s investment portfolio totaled $126.0 billion in investments and cash and cash equivalents as of December 31, 2025, led by fixed maturity securities and mortgage loans.
Brighthouse also emphasized statutory capital strength. Preliminary combined total adjusted capital was $5.3 billion and normalized statutory earnings were $1.0 billion for 2025, compared with a normalized statutory loss in 2024. These measures, along with non-GAAP metrics such as adjusted earnings and adjusted net investment income, are used by management to assess underlying performance and capital-generating capacity.
A key strategic development is the pending merger with Aquarian Capital LLC. Under a definitive agreement announced in November 2025, an affiliate of Aquarian Capital will acquire Brighthouse Financial for $70.00 per share in an all-cash transaction valued at approximately $4.1 billion. At a special meeting held on February 12, 2026, Brighthouse shareholders voted to adopt the merger agreement. The transaction is expected to close in 2026, subject to customary closing conditions, including required insurance regulatory approvals.
Positive
- None.
Negative
- None.
Insights
Solid capital and sales with softer earnings and a transformative sale.
Brighthouse shows strong balance sheet and sales momentum alongside more volatile earnings. Net income available to shareholders rose to $331 million in 2025, but full-year adjusted earnings, less notable items, declined to $931 million from $1,209 million, indicating weaker underlying profitability.
Capital and liquidity appear robust. The preliminary combined RBC ratio of 456% sits above the stated 400%–450% target range, and holding company liquid assets total $0.9 billion. Record 2025 annuity sales of $10.3 billion and record life sales of $143 million show continued franchise strength in core product lines.
The announced all-cash acquisition by Aquarian Capital at $70.00 per share, valued around $4.1 billion, is a major strategic event, now approved by shareholders and pending regulatory clearances. The eventual impact for investors will depend on closing timing and any remaining conditions described for 2026 completion.
8-K Event Classification

| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of principal executive offices) | (Zip Code) | ||||||||||||||||
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||
Emerging growth company | |||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ | ||||||||||
| Exhibit No. | Description | ||||
99.1** | News release of Brighthouse Financial, Inc., dated February 23, 2026, announcing its results for the quarter and full year ended December 31, 2025 | ||||
99.2** | Financial Supplement for the quarter ended December 31, 2025 | ||||
| 104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
| BRIGHTHOUSE FINANCIAL, INC. | |||||||||||
| By: | /s/ Melissa B. Pavlovich | ||||||||||
| Name: | Melissa B. Pavlovich | ||||||||||
| Title: | Chief Accounting Officer | ||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| As of or For the Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
| December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Total | Per share | Total | Per share | |||||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders (1) | $112 | $1.93 | $646 | $10.79 | ||||||||||||||||||||||||||||||||||||||||||||||
Adjusted earnings (1) | $214 | $3.70 | $304 | $5.07 | ||||||||||||||||||||||||||||||||||||||||||||||
Adjusted earnings, less notable items (1) | $227 | $3.93 | $352 | $5.88 | ||||||||||||||||||||||||||||||||||||||||||||||
Weighted average common shares outstanding - diluted (1) | 57,829,186 | N/A | 59,823,854 | N/A | ||||||||||||||||||||||||||||||||||||||||||||||
| Book value | $5,069 | $88.66 | $3,260 | $55.60 | ||||||||||||||||||||||||||||||||||||||||||||||
| Book value, excluding AOCI | $8,798 | $153.89 | $8,538 | $145.63 | ||||||||||||||||||||||||||||||||||||||||||||||
| Ending common shares outstanding | 57,171,217 | N/A | 58,629,049 | N/A | ||||||||||||||||||||||||||||||||||||||||||||||
(1) Per share amounts are on a diluted basis and may not recalculate due to rounding. See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||||||||||||||||||||||||||||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||
ADJUSTED EARNINGS (LOSS) (1) | December 31, 2025 | September 30, 2025 | December 31, 2024 | |||||||||||||||||
| Annuities | $304 | $304 | $279 | |||||||||||||||||
Life | $18 | $40 | $52 | |||||||||||||||||
Run-off | $(58) | $641 | $(27) | |||||||||||||||||
Corporate & Other | $(50) | $(15) | $— | |||||||||||||||||
| (1) The company uses the term "adjusted loss" throughout this news release to refer to negative adjusted earnings values. | ||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||
| December 31, 2025 | September 30, 2025 | December 31, 2024 | ||||||||||||||||||
| Annuities (1) | $2,734 | $2,731 | $2,239 | |||||||||||||||||
| Life | $36 | $38 | $33 | |||||||||||||||||
| (1) Annuities sales include sales of a fixed index annuity product, which represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. Sales of this product were $142 million for the fourth quarter of 2025, $126 million for the third quarter of 2025 and $62 million for the fourth quarter of 2024. | ||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||
| December 31, 2025 | September 30, 2025 | December 31, 2024 | ||||||||||||||||||
| Net investment income | $1,328 | $1,334 | $1,373 | |||||||||||||||||
| Adjusted net investment income | $1,334 | $1,327 | $1,376 | |||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| As of | ||||||||||||||||||||
December 31, 2025 (1) | September 30, 2025 | December 31, 2024 | ||||||||||||||||||
| Statutory combined total adjusted capital | $5.3 | $5.4 | $5.4 | |||||||||||||||||
(1) Reflects preliminary statutory results as of December 31, 2025. | ||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
FOR INVESTORS Dana Amante (980) 949-3073 damante@brighthousefinancial.com | FOR MEDIA Meghan Lantier (980) 949-4142 mlantier@brighthousefinancial.com | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| Non-GAAP financial measures: | Most directly comparable GAAP financial measures: | ||||
| adjusted earnings | net income (loss) available to shareholders (1) | ||||
| adjusted earnings, less notable items | net income (loss) available to shareholders (1) | ||||
| adjusted revenues | revenues | ||||
| adjusted expenses | expenses | ||||
| adjusted earnings per common share | earnings per common share, diluted (1) | ||||
| adjusted earnings per common share, less notable items | earnings per common share, diluted (1) | ||||
| adjusted return on common equity | return on common equity (2) | ||||
| adjusted return on common equity, less notable items | return on common equity (2) | ||||
| adjusted net investment income | net investment income | ||||
| adjusted net investment income yield | net investment income yield | ||||
__________________ | |||||
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.'s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share. | |||||
| (2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.'s common stockholders' equity. | |||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||
| Revenues | December 31, 2025 | September 30, 2025 | December 31, 2024 | |||||||||||||||||
| Premiums | $173 | $170 | $207 | |||||||||||||||||
| Universal life and investment-type product policy fees | 534 | 531 | 540 | |||||||||||||||||
| Net investment income | 1,328 | 1,334 | 1,373 | |||||||||||||||||
| Other revenues | 133 | 143 | 150 | |||||||||||||||||
| Revenues before NIGL and NDGL | 2,168 | 2,178 | 2,270 | |||||||||||||||||
| Net investment gains (losses) | (23) | 48 | (73) | |||||||||||||||||
| Net derivative gains (losses) | (456) | (410) | (992) | |||||||||||||||||
| Total revenues | $1,689 | $1,816 | $1,205 | |||||||||||||||||
| Expenses | ||||||||||||||||||||
| Policyholder benefits and claims | $697 | $(252) | $662 | |||||||||||||||||
| Interest credited to policyholder account balances | 529 | 561 | 569 | |||||||||||||||||
| Amortization of DAC and VOBA | 159 | 153 | 148 | |||||||||||||||||
| Change in market risk benefits | (349) | 289 | (1,487) | |||||||||||||||||
| Interest expense on debt | 38 | 38 | 38 | |||||||||||||||||
| Other expenses | 465 | 442 | 441 | |||||||||||||||||
| Total expenses | 1,539 | 1,231 | 371 | |||||||||||||||||
| Income (loss) before provision for income tax | 150 | 585 | 834 | |||||||||||||||||
| Provision for income tax expense (benefit) | 12 | 104 | 162 | |||||||||||||||||
| Net income (loss) | 138 | 481 | 672 | |||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | 1 | 2 | 1 | |||||||||||||||||
| Net income (loss) attributable to Brighthouse Financial, Inc. | 137 | 479 | 671 | |||||||||||||||||
| Less: Preferred stock dividends | 25 | 26 | 25 | |||||||||||||||||
| Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $112 | $453 | $646 | |||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| As of | ||||||||||||||||||||
| ASSETS | December 31, 2025 | September 30, 2025 | December 31, 2024 | |||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturity securities available-for-sale | $82,014 | $81,537 | $80,055 | |||||||||||||||||
| Trading securities | 506 | 528 | — | |||||||||||||||||
| Equity securities | 79 | 78 | 77 | |||||||||||||||||
| Mortgage loans | 22,755 | 22,862 | 23,286 | |||||||||||||||||
| Policy loans | 1,450 | 1,439 | 2,024 | |||||||||||||||||
| Limited partnerships and limited liability companies | 4,696 | 4,816 | 4,827 | |||||||||||||||||
| Short-term investments | 1,197 | 778 | 1,868 | |||||||||||||||||
| Other invested assets | 7,932 | 8,842 | 5,250 | |||||||||||||||||
| Total investments | 120,629 | 120,880 | 117,387 | |||||||||||||||||
| Cash and cash equivalents | 5,387 | 6,606 | 5,045 | |||||||||||||||||
| Accrued investment income | 1,260 | 1,350 | 1,277 | |||||||||||||||||
| Reinsurance recoverables | 20,903 | 20,400 | 20,515 | |||||||||||||||||
| Premiums and other receivables | 676 | 844 | 611 | |||||||||||||||||
| DAC and VOBA | 4,567 | 4,603 | 4,710 | |||||||||||||||||
| Current income tax recoverable | 16 | 17 | 19 | |||||||||||||||||
| Deferred income tax asset | 1,442 | 1,531 | 1,875 | |||||||||||||||||
| Market risk benefit assets | 1,060 | 979 | 1,092 | |||||||||||||||||
| Other assets | 332 | 342 | 370 | |||||||||||||||||
| Separate account assets | 85,528 | 87,127 | 85,636 | |||||||||||||||||
| Total assets | $241,800 | $244,679 | $238,537 | |||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Future policy benefits | $32,025 | $32,021 | $31,475 | |||||||||||||||||
| Policyholder account balances | 87,952 | 88,703 | 87,989 | |||||||||||||||||
| Market risk benefit liabilities | 8,063 | 8,529 | 8,329 | |||||||||||||||||
| Other policy-related balances | 3,893 | 3,918 | 3,878 | |||||||||||||||||
| Payables for collateral under securities loaned and other transactions | 4,705 | 4,347 | 3,891 | |||||||||||||||||
| Long-term debt | 3,155 | 3,155 | 3,155 | |||||||||||||||||
| Other liabilities | 9,646 | 10,451 | 9,160 | |||||||||||||||||
| Separate account liabilities | 85,528 | 87,127 | 85,636 | |||||||||||||||||
| Total liabilities | 234,967 | 238,251 | 233,513 | |||||||||||||||||
| Equity | ||||||||||||||||||||
| Preferred stock, at par value | — | — | — | |||||||||||||||||
| Common stock, at par value | 1 | 1 | 1 | |||||||||||||||||
| Additional paid-in capital | 13,870 | 13,893 | 13,927 | |||||||||||||||||
| Retained earnings (deficit) | (686) | (823) | (1,119) | |||||||||||||||||
| Treasury stock | (2,688) | (2,688) | (2,572) | |||||||||||||||||
| Accumulated other comprehensive income (loss) | (3,729) | (4,020) | (5,278) | |||||||||||||||||
| Total Brighthouse Financial, Inc.’s stockholders’ equity | 6,768 | 6,363 | 4,959 | |||||||||||||||||
| Noncontrolling interests | 65 | 65 | 65 | |||||||||||||||||
| Total equity | 6,833 | 6,428 | 5,024 | |||||||||||||||||
| Total liabilities and equity | $241,800 | $244,679 | $238,537 | |||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS | December 31, 2025 | September 30, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders | $112 | $453 | $646 | $331 | $286 | |||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (23) | 48 | (73) | (97) | (295) | |||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (7) | 7 | — | — | — | |||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | (455) | (410) | (995) | (1,792) | (3,699) | |||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | 349 | (289) | 1,487 | 268 | 2,673 | |||||||||||||||||||||||||||||||||
| Less: Market value adjustments | 6 | (10) | 14 | (8) | 13 | |||||||||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | 28 | 137 | (91) | 343 | 275 | |||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | 214 | 970 | 304 | 1,617 | 1,319 | |||||||||||||||||||||||||||||||||
| Less: Notable items | (13) | 709 | (48) | 686 | 110 | |||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items | $227 | $261 | $352 | $931 | $1,209 | |||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS, PER COMMON SHARE (1) | ||||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders per common share | $1.93 | $7.89 | $10.79 | $5.71 | $4.64 | |||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (0.40) | 0.83 | (1.22) | (1.67) | (4.79) | |||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (0.12) | 0.12 | — | — | — | |||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | (7.87) | (7.13) | (16.63) | (30.93) | (60.05) | |||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | 6.04 | (5.02) | 24.86 | 4.63 | 43.39 | |||||||||||||||||||||||||||||||||
| Less: Market value adjustments | 0.10 | (0.17) | 0.23 | (0.14) | 0.21 | |||||||||||||||||||||||||||||||||
| Less: Provision for income tax (expense) benefit on reconciling adjustments | 0.48 | 2.38 | (1.52) | 5.92 | 4.46 | |||||||||||||||||||||||||||||||||
| Less: Impact of inclusion of dilutive shares | — | — | — | — | — | |||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) per common share | 3.70 | 16.87 | 5.07 | 27.92 | 21.40 | |||||||||||||||||||||||||||||||||
| Less: Notable items | (0.22) | 12.33 | (0.80) | 11.84 | 1.79 | |||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items per common share | $3.93 | $4.54 | $5.88 | $16.07 | $19.63 | |||||||||||||||||||||||||||||||||
(1) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||||||||||||||||||||||||||||||||||
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 | ![]() | ||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
ADJUSTED NET INVESTMENT INCOME (1) | December 31, 2025 | September 30, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||
| Net investment income | $1,328 | $1,334 | $1,373 | |||||||||||||||||||||||||||||
Add: Investment hedge adjustments | (1) | — | 3 | |||||||||||||||||||||||||||||
Less: Investment gains (losses) on trading securities | (7) | 7 | — | |||||||||||||||||||||||||||||
| Adjusted net investment income | $1,334 | $1,327 | $1,376 | |||||||||||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| ADJUSTED NET INVESTMENT INCOME YIELD (1) | December 31, 2025 | September 30, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||
| Investment income yield | 4.60% | 4.54% | 4.64% | |||||||||||||||||||||||||||||
| Investment fees and expenses | (0.16)% | (0.14)% | (0.13)% | |||||||||||||||||||||||||||||
| Adjusted net investment income yield | 4.44% | 4.40% | 4.51% | |||||||||||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS | December 31, 2025 | September 30, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||
| Actuarial items and other insurance adjustments | $13 | $(709) | $48 | |||||||||||||||||||||||||||||
| Total notable items (1) | $13 | $(709) | $48 | |||||||||||||||||||||||||||||
NOTABLE ITEMS BY SEGMENT | ||||||||||||||||||||||||||||||||
| Annuities | $— | $7 | $48 | |||||||||||||||||||||||||||||
| Life | 6 | (11) | — | |||||||||||||||||||||||||||||
| Run-off | 7 | (705) | — | |||||||||||||||||||||||||||||
| Corporate & Other | — | — | — | |||||||||||||||||||||||||||||
| Total notable items (1) | $13 | $(709) | $48 | |||||||||||||||||||||||||||||
| (1) See Non-GAAP and Other Financial Disclosures discussion in this news release. | ||||||||||||||||||||||||||||||||
| Table of Contents | Financial Results | |||||||
1 | Key Metrics | |||||||
2 | GAAP Statements of Operations | |||||||
3 | GAAP Balance Sheets | |||||||
Earnings and Select Metrics from Segments | ||||||||
5 | Statements of Adjusted Earnings by Segment | |||||||
7 | Annuities — Statements of Adjusted Earnings | |||||||
8 | Annuities — Select Operating Metrics | |||||||
10 | Life — Statements of Adjusted Earnings | |||||||
11 | Life — Select Operating Metrics | |||||||
13 | Run-off — Statements of Adjusted Earnings | |||||||
14 | Run-off — Select Operating Metrics | |||||||
15 | Corporate & Other — Statements of Adjusted Earnings and Select Operating Metrics | |||||||
| Other Information | ||||||||
17 | Change in Market Risk Benefits and Net Derivative Gains (Losses) | |||||||
18 | Notable Items | |||||||
19 | Variable Annuity Separate Account Returns and Allocations | |||||||
20 | Summary of Investments | |||||||
21 | Statutory Statement of Operations Information | |||||||
22 | Statutory Balance Sheet and Surplus Information | |||||||
| Appendix | ||||||||
A-1 | Note Regarding Forward-Looking Statements | |||||||
A-2 | Non-GAAP and Other Financial Disclosures | |||||||
A-6 | Acronyms | |||||||
A-7 | Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings (Loss) and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings (Loss) per Common Share and Adjusted Earnings, Less Notable Items per Common Share | |||||||
A-8 | Reconciliation of Return on Common Equity to Adjusted Return on Common Equity, Excluding AOCI | |||||||
A-9 | Reconciliation of Total Revenues to Adjusted Revenues and Reconciliation of Total Expenses to Adjusted Expenses | |||||||
A-10 | Investment Reconciliation Details | |||||||


| Financial Supplement | 1 | |||||||||||||
| As of or For the Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
| Financial Results and Metrics (1) | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders | $112 | $453 | $60 | $(294) | $646 | |||||||||||||||||||||||||||||||||||||||
Adjusted earnings (2) | $214 | $970 | $198 | $235 | $304 | |||||||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items (2) | $227 | $261 | $198 | $245 | $352 | |||||||||||||||||||||||||||||||||||||||
| Total corporate expenses (3) | $234 | $205 | $202 | $239 | $210 | |||||||||||||||||||||||||||||||||||||||
Combined total adjusted capital (4), (5) | $5,300 | $5,400 | $5,560 | $5,549 | $5,373 | |||||||||||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4), (5), (6) | 456% | 435%-455% | 405%-425% | 420%-440% | 402% | |||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s stockholders’ equity | $6,768 | $6,363 | $5,673 | $5,239 | $4,959 | |||||||||||||||||||||||||||||||||||||||
| Less: Preferred stock, net | 1,699 | 1,699 | 1,699 | 1,699 | 1,699 | |||||||||||||||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s common stockholders’ equity, including AOCI | $5,069 | $4,664 | $3,974 | $3,540 | $3,260 | |||||||||||||||||||||||||||||||||||||||
| Less: AOCI | (3,729) | (4,020) | (4,257) | (4,670) | (5,278) | |||||||||||||||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $8,798 | $8,684 | $8,231 | $8,210 | $8,538 | |||||||||||||||||||||||||||||||||||||||
Return on Common Equity (1) | ||||||||||||||||||||||||||||||||||||||||||||
| Return on common equity | 8.1% | 22.5% | 16.5% | 16.4% | 9.4% | |||||||||||||||||||||||||||||||||||||||
| Return on common equity, excluding AOCI | 3.9% | 10.4% | 6.9% | 6.3% | 3.5% | |||||||||||||||||||||||||||||||||||||||
| Adjusted return on common equity, excluding AOCI | 19.0% | 20.5% | 18.4% | 20.4% | 16.2% | |||||||||||||||||||||||||||||||||||||||
Earnings Per Common Share, Diluted (1), (7) | ||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders per common share | $1.93 | $7.89 | $1.02 | $(5.04) | $10.79 | |||||||||||||||||||||||||||||||||||||||
| Adjusted earnings per common share | $3.70 | $16.87 | $3.43 | $4.01 | $5.07 | |||||||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items per common share | $3.93 | $4.54 | $3.43 | $4.17 | $5.88 | |||||||||||||||||||||||||||||||||||||||
| Weighted average common shares outstanding | 57,829,186 | 57,512,901 | 57,734,170 | 58,697,818 | 59,823,854 | |||||||||||||||||||||||||||||||||||||||
| Book Value Per Common Share | ||||||||||||||||||||||||||||||||||||||||||||
| Book value per common share (1) | $88.66 | $81.60 | $69.57 | $61.17 | $55.60 | |||||||||||||||||||||||||||||||||||||||
| Book value per common share, excluding AOCI (1) | $153.89 | $151.94 | $144.09 | $141.87 | $145.63 | |||||||||||||||||||||||||||||||||||||||
| Ending common shares outstanding | 57,171,217 | 57,153,571 | 57,122,494 | 57,868,389 | 58,629,049 | |||||||||||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||
| (2) See additional information regarding notable items on page 18. | ||||||||||||||||||||||||||||||||||||||||||||
| (3) Includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation. | ||||||||||||||||||||||||||||||||||||||||||||
(4) Reflects preliminary statutory results as of or for the three months ended December 31, 2025. See additional information on page 22. | ||||||||||||||||||||||||||||||||||||||||||||
(5) Statutory results as of or for the three months ended December 31, 2024 include a $100 million capital contribution to Brighthouse Life Insurance Company made subsequent to December 31, 2024. See additional information on page 22. | ||||||||||||||||||||||||||||||||||||||||||||
(6) The RBC ratio is reported as a preliminary range for all periods, except those ended December 31. | ||||||||||||||||||||||||||||||||||||||||||||
(7) For loss periods, dilutive shares were not included in the calculation of net income (loss) available to shareholders per common share or adjusted earnings (loss) per common share as inclusion of such shares would have an anti-dilutive effect. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | 2 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| Revenues | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Premiums | $173 | $170 | $166 | $186 | $207 | $695 | $770 | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 534 | 531 | 553 | 543 | 540 | 2,161 | 2,116 | |||||||||||||||||||||||||||||||||||||
| Net investment income | 1,328 | 1,334 | 1,285 | 1,297 | 1,373 | 5,244 | 5,222 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 133 | 143 | 143 | 136 | 150 | 555 | 579 | |||||||||||||||||||||||||||||||||||||
| Revenues before NIGL and NDGL | 2,168 | 2,178 | 2,147 | 2,162 | 2,270 | 8,655 | 8,687 | |||||||||||||||||||||||||||||||||||||
| Net investment gains (losses) | (23) | 48 | (39) | (83) | (73) | (97) | (295) | |||||||||||||||||||||||||||||||||||||
| Net derivative gains (losses) | (456) | (410) | (1,237) | 311 | (992) | (1,792) | (3,668) | |||||||||||||||||||||||||||||||||||||
| Total revenues | $1,689 | $1,816 | $871 | $2,390 | $1,205 | $6,766 | $4,724 | |||||||||||||||||||||||||||||||||||||
| Expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $697 | $(252) | $711 | $649 | $662 | $1,805 | $2,294 | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 529 | 561 | 537 | 561 | 569 | 2,188 | 2,136 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 159 | 153 | 149 | 148 | 148 | 609 | 599 | |||||||||||||||||||||||||||||||||||||
| Change in market risk benefits | (349) | 289 | (1,101) | 893 | (1,487) | (268) | (2,673) | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | 38 | 38 | 38 | 38 | 38 | 152 | 152 | |||||||||||||||||||||||||||||||||||||
| Other expenses | 465 | 442 | 444 | 455 | 441 | 1,806 | 1,794 | |||||||||||||||||||||||||||||||||||||
| Total expenses | 1,539 | 1,231 | 778 | 2,744 | 371 | 6,292 | 4,302 | |||||||||||||||||||||||||||||||||||||
| Income (loss) before provision for income tax | 150 | 585 | 93 | (354) | 834 | 474 | 422 | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 12 | 104 | 8 | (88) | 162 | 36 | 29 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) | 138 | 481 | 85 | (266) | 672 | 438 | 393 | |||||||||||||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | 1 | 2 | — | 2 | 1 | 5 | 5 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) attributable to Brighthouse Financial, Inc. | 137 | 479 | 85 | (268) | 671 | 433 | 388 | |||||||||||||||||||||||||||||||||||||
| Less: Preferred stock dividends | 25 | 26 | 25 | 26 | 25 | 102 | 102 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $112 | $453 | $60 | $(294) | $646 | $331 | $286 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 3 | |||||||||||||
| As of | ||||||||||||||||||||||||||||||||
| ASSETS | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Investments: | ||||||||||||||||||||||||||||||||
| Fixed maturity securities available-for-sale | $82,014 | $81,537 | $80,835 | $80,640 | $80,055 | |||||||||||||||||||||||||||
| Trading securities | 506 | 528 | 520 | 365 | — | |||||||||||||||||||||||||||
| Equity securities | 79 | 78 | 74 | 73 | 77 | |||||||||||||||||||||||||||
| Mortgage loans | 22,755 | 22,862 | 22,993 | 23,051 | 23,286 | |||||||||||||||||||||||||||
| Policy loans | 1,450 | 1,439 | 1,425 | 1,436 | 2,024 | |||||||||||||||||||||||||||
| Limited partnerships and limited liability companies | 4,696 | 4,816 | 4,798 | 4,839 | 4,827 | |||||||||||||||||||||||||||
| Short-term investments | 1,197 | 778 | 1,170 | 1,569 | 1,868 | |||||||||||||||||||||||||||
| Other invested assets | 7,932 | 8,842 | 8,932 | 5,284 | 5,250 | |||||||||||||||||||||||||||
| Total investments | 120,629 | 120,880 | 120,747 | 117,257 | 117,387 | |||||||||||||||||||||||||||
| Cash and cash equivalents | 5,387 | 6,606 | 5,540 | 4,667 | 5,045 | |||||||||||||||||||||||||||
| Accrued investment income | 1,260 | 1,350 | 1,235 | 1,267 | 1,277 | |||||||||||||||||||||||||||
| Reinsurance recoverables | 20,903 | 20,400 | 20,701 | 20,454 | 20,515 | |||||||||||||||||||||||||||
| Premiums and other receivables | 676 | 844 | 557 | 734 | 611 | |||||||||||||||||||||||||||
| DAC and VOBA | 4,567 | 4,603 | 4,636 | 4,672 | 4,710 | |||||||||||||||||||||||||||
| Current income tax recoverable | 16 | 17 | 17 | 20 | 19 | |||||||||||||||||||||||||||
| Deferred income tax asset | 1,442 | 1,531 | 1,695 | 1,808 | 1,875 | |||||||||||||||||||||||||||
| Market risk benefit assets | 1,060 | 979 | 1,084 | 914 | 1,092 | |||||||||||||||||||||||||||
| Other assets | 332 | 342 | 348 | 364 | 370 | |||||||||||||||||||||||||||
| Separate account assets | 85,528 | 87,127 | 86,085 | 82,524 | 85,636 | |||||||||||||||||||||||||||
| Total assets | $241,800 | $244,679 | $242,645 | $234,681 | $238,537 | |||||||||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||
| Future policy benefits | $32,025 | $32,021 | $31,974 | $31,834 | $31,475 | |||||||||||||||||||||||||||
| Policyholder account balances | 87,952 | 88,703 | 88,046 | 85,618 | 87,989 | |||||||||||||||||||||||||||
| Market risk benefit liabilities | 8,063 | 8,529 | 8,051 | 9,165 | 8,329 | |||||||||||||||||||||||||||
| Other policy-related balances | 3,893 | 3,918 | 3,977 | 3,866 | 3,878 | |||||||||||||||||||||||||||
| Payables for collateral under securities loaned and other transactions | 4,705 | 4,347 | 3,994 | 3,904 | 3,891 | |||||||||||||||||||||||||||
| Long-term debt | 3,155 | 3,155 | 3,155 | 3,155 | 3,155 | |||||||||||||||||||||||||||
| Other liabilities | 9,646 | 10,451 | 11,625 | 9,311 | 9,160 | |||||||||||||||||||||||||||
| Separate account liabilities | 85,528 | 87,127 | 86,085 | 82,524 | 85,636 | |||||||||||||||||||||||||||
| Total liabilities | 234,967 | 238,251 | 236,907 | 229,377 | 233,513 | |||||||||||||||||||||||||||
| Equity | ||||||||||||||||||||||||||||||||
| Preferred stock, at par value | — | — | — | — | — | |||||||||||||||||||||||||||
| Common stock, at par value | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||||||
| Additional paid-in capital | 13,870 | 13,893 | 13,918 | 13,939 | 13,927 | |||||||||||||||||||||||||||
| Retained earnings (deficit) | (686) | (823) | (1,302) | (1,387) | (1,119) | |||||||||||||||||||||||||||
| Treasury stock | (2,688) | (2,688) | (2,687) | (2,644) | (2,572) | |||||||||||||||||||||||||||
| Accumulated other comprehensive income (loss) | (3,729) | (4,020) | (4,257) | (4,670) | (5,278) | |||||||||||||||||||||||||||
| Total Brighthouse Financial, Inc.’s stockholders’ equity | 6,768 | 6,363 | 5,673 | 5,239 | 4,959 | |||||||||||||||||||||||||||
| Noncontrolling interests | 65 | 65 | 65 | 65 | 65 | |||||||||||||||||||||||||||
| Total equity | 6,833 | 6,428 | 5,738 | 5,304 | 5,024 | |||||||||||||||||||||||||||
| Total liabilities and equity | $241,800 | $244,679 | $242,645 | $234,681 | $238,537 | |||||||||||||||||||||||||||


| Financial Supplement | 5 | |||||||||||||
| For the Three Months Ended December 31, 2025 | ||||||||||||||||||||||||||||||||
| Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
| Premiums | $72 | $101 | $— | $— | $173 | |||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 364 | 83 | 87 | — | 534 | |||||||||||||||||||||||||||
| Net investment income | 776 | 111 | 305 | 142 | 1,334 | |||||||||||||||||||||||||||
| Other revenues | 122 | 3 | 6 | 2 | 133 | |||||||||||||||||||||||||||
| Total adjusted revenues | $1,334 | $298 | $398 | $144 | $2,174 | |||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $123 | $182 | $392 | $— | $697 | |||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 352 | 30 | 56 | 97 | 535 | |||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 138 | 21 | — | — | 159 | |||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | 38 | 38 | |||||||||||||||||||||||||||
| Other operating costs | 344 | 46 | 31 | 44 | 465 | |||||||||||||||||||||||||||
| Total adjusted expenses | 957 | 279 | 479 | 179 | 1,894 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | 377 | 19 | (81) | (35) | 280 | |||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 73 | 1 | (23) | (11) | 40 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) after provision for income tax | 304 | 18 | (58) | (24) | 240 | |||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 1 | 1 | |||||||||||||||||||||||||||
| Less: Preferred stock dividends | — | — | — | 25 | 25 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) | $304 | $18 | $(58) | $(50) | $214 | |||||||||||||||||||||||||||
| For the Three Months Ended December 31, 2024 | ||||||||||||||||||||||||||||||||
| Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
| Premiums | $81 | $126 | $— | $— | $207 | |||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 380 | 62 | 98 | — | 540 | |||||||||||||||||||||||||||
| Net investment income | 752 | 126 | 328 | 170 | 1,376 | |||||||||||||||||||||||||||
| Other revenues | 137 | 4 | 7 | 2 | 150 | |||||||||||||||||||||||||||
| Total adjusted revenues | $1,350 | $318 | $433 | $172 | $2,273 | |||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $137 | $158 | $367 | $— | $662 | |||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 379 | 29 | 61 | 114 | 583 | |||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 125 | 23 | — | — | 148 | |||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | 38 | 38 | |||||||||||||||||||||||||||
| Other operating costs | 359 | 44 | 39 | (1) | 441 | |||||||||||||||||||||||||||
| Total adjusted expenses | 1,000 | 254 | 467 | 151 | 1,872 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | 350 | 64 | (34) | 21 | 401 | |||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 71 | 12 | (7) | (5) | 71 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) after provision for income tax | 279 | 52 | (27) | 26 | 330 | |||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 1 | 1 | |||||||||||||||||||||||||||
| Less: Preferred stock dividends | — | — | — | 25 | 25 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) | $279 | $52 | $(27) | $— | $304 | |||||||||||||||||||||||||||

| Financial Supplement | 6 | |||||||||||||
| For the Year Ended December 31, 2025 | ||||||||||||||||||||||||||||||||
| Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
| Premiums | $265 | $428 | $2 | $— | $695 | |||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 1,517 | 294 | 350 | — | 2,161 | |||||||||||||||||||||||||||
| Net investment income | 3,056 | 432 | 1,152 | 604 | 5,244 | |||||||||||||||||||||||||||
| Other revenues | 507 | 15 | 28 | 5 | 555 | |||||||||||||||||||||||||||
| Total adjusted revenues | $5,345 | $1,169 | $1,532 | $609 | $8,655 | |||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $456 | $724 | $625 | $— | $1,805 | |||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 1,421 | 115 | 235 | 409 | 2,180 | |||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 522 | 87 | — | — | 609 | |||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | 152 | 152 | |||||||||||||||||||||||||||
| Other operating costs | 1,397 | 198 | 128 | 83 | 1,806 | |||||||||||||||||||||||||||
| Total adjusted expenses | 3,796 | 1,124 | 988 | 644 | 6,552 | |||||||||||||||||||||||||||
Adjusted earnings (loss) before provision for income tax | 1,549 | 45 | 544 | (35) | 2,103 | |||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 295 | 4 | 108 | (28) | 379 | |||||||||||||||||||||||||||
Adjusted earnings (loss) after provision for income tax | 1,254 | 41 | 436 | (7) | 1,724 | |||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 5 | 5 | |||||||||||||||||||||||||||
| Less: Preferred stock dividends | — | — | — | 102 | 102 | |||||||||||||||||||||||||||
Adjusted earnings (loss) | $1,254 | $41 | $436 | $(114) | $1,617 | |||||||||||||||||||||||||||
| For the Year Ended December 31, 2024 | ||||||||||||||||||||||||||||||||
| Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
| Premiums | $289 | $480 | $1 | $— | $770 | |||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 1,611 | 174 | 331 | — | 2,116 | |||||||||||||||||||||||||||
| Net investment income | 2,859 | 466 | 1,234 | 694 | 5,253 | |||||||||||||||||||||||||||
| Other revenues | 523 | 15 | 29 | 12 | 579 | |||||||||||||||||||||||||||
| Total adjusted revenues | $5,282 | $1,135 | $1,595 | $706 | $8,718 | |||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $479 | $710 | $1,105 | $— | $2,294 | |||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 1,351 | 105 | 243 | 450 | 2,149 | |||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 505 | 94 | — | — | 599 | |||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | 152 | 152 | |||||||||||||||||||||||||||
| Other operating costs | 1,399 | 188 | 166 | 41 | 1,794 | |||||||||||||||||||||||||||
| Total adjusted expenses | 3,734 | 1,097 | 1,514 | 643 | 6,988 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | 1,548 | 38 | 81 | 63 | 1,730 | |||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 297 | 5 | 16 | (14) | 304 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) after provision for income tax | 1,251 | 33 | 65 | 77 | 1,426 | |||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 5 | 5 | |||||||||||||||||||||||||||
| Less: Preferred stock dividends | — | — | — | 102 | 102 | |||||||||||||||||||||||||||
| Adjusted earnings (loss) | $1,251 | $33 | $65 | $(30) | $1,319 | |||||||||||||||||||||||||||

| Financial Supplement | 7 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| Adjusted revenues | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Premiums | $72 | $68 | $60 | $65 | $81 | $265 | $289 | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 364 | 372 | 385 | 396 | 380 | 1,517 | 1,611 | |||||||||||||||||||||||||||||||||||||
| Net investment income | 776 | 770 | 757 | 753 | 752 | 3,056 | 2,859 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 122 | 126 | 129 | 130 | 137 | 507 | 523 | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $1,334 | $1,336 | $1,331 | $1,344 | $1,350 | $5,345 | $5,282 | |||||||||||||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $123 | $125 | $98 | $110 | $137 | $456 | $479 | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 352 | 357 | 354 | 358 | 379 | 1,421 | 1,351 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 138 | 131 | 127 | 126 | 125 | 522 | 505 | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Other operating costs | 344 | 348 | 342 | 363 | 359 | 1,397 | 1,399 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | 957 | 961 | 921 | 957 | 1,000 | 3,796 | 3,734 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings before provision for income tax | 377 | 375 | 410 | 387 | 350 | 1,549 | 1,548 | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 73 | 71 | 78 | 73 | 71 | 295 | 297 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings | $304 | $304 | $332 | $314 | $279 | $1,254 | $1,251 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 8 | |||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| VARIABLE AND SHIELD LEVEL ANNUITIES ACCOUNT VALUE (1) | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Account value, beginning of period | $130,470 | $127,180 | $120,963 | $125,121 | $128,234 | |||||||||||||||||||||||||||
| Premiums and deposits (2) | 2,342 | 2,309 | 2,188 | 2,201 | 2,146 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (5,009) | (4,594) | (4,190) | (4,156) | (4,273) | |||||||||||||||||||||||||||
| Net flows (3) | (2,667) | (2,285) | (2,002) | (1,955) | (2,127) | |||||||||||||||||||||||||||
| Investment performance (4) | 2,621 | 6,129 | 8,758 | (1,715) | (453) | |||||||||||||||||||||||||||
| Policy charges and other | (518) | (554) | (539) | (488) | (533) | |||||||||||||||||||||||||||
| Account value, end of period | $129,906 | $130,470 | $127,180 | $120,963 | $125,121 | |||||||||||||||||||||||||||
| FIXED ANNUITIES ACCOUNT VALUE (5) | ||||||||||||||||||||||||||||||||
| Account value, beginning of period | $18,456 | $19,339 | $19,355 | $19,577 | $19,840 | |||||||||||||||||||||||||||
| Premiums and deposits (2) | 469 | 506 | 504 | 131 | 162 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (1,277) | (1,615) | (688) | (562) | (646) | |||||||||||||||||||||||||||
| Net flows (3) | (808) | (1,109) | (184) | (431) | (484) | |||||||||||||||||||||||||||
| Interest credited | 164 | 170 | 169 | 168 | 171 | |||||||||||||||||||||||||||
| Other | 8 | 56 | (1) | 41 | 50 | |||||||||||||||||||||||||||
| Account value, end of period | $17,820 | $18,456 | $19,339 | $19,355 | $19,577 | |||||||||||||||||||||||||||
INSTITUTIONAL GROUP ANNUITIES ACCOUNT VALUE (1) | ||||||||||||||||||||||||||||||||
Institutional group annuities account value, end of period | $569 | $584 | $566 | $401 | $370 | |||||||||||||||||||||||||||
| INCOME ANNUITIES (1) | ||||||||||||||||||||||||||||||||
| Income annuity insurance liabilities, end of period | $4,788 | $4,755 | $4,645 | $4,583 | $4,518 | |||||||||||||||||||||||||||
| (1) Includes general account and separate account. | ||||||||||||||||||||||||||||||||
| (2) Includes premiums and deposits directed to the general account investment option of variable products. | ||||||||||||||||||||||||||||||||
| (3) Deposits and withdrawals include policy exchanges. | ||||||||||||||||||||||||||||||||
| (4) Includes the interest credited on the general account option of variable products. | ||||||||||||||||||||||||||||||||
| (5) Includes fixed index annuities. | ||||||||||||||||||||||||||||||||

| Financial Supplement | 9 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| VARIABLE AND SHIELD LEVEL ANNUITY SALES | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Shield Level Annuities (1) | $2,074 | $2,052 | $1,925 | $1,957 | $1,893 | $8,008 | $7,671 | |||||||||||||||||||||||||||||||||||||
| GMWB | 118 | 115 | 109 | 103 | 98 | 445 | 355 | |||||||||||||||||||||||||||||||||||||
| GMDB only | 69 | 55 | 67 | 58 | 72 | 249 | 252 | |||||||||||||||||||||||||||||||||||||
| GMIB | 2 | 3 | 4 | 4 | 6 | 13 | 22 | |||||||||||||||||||||||||||||||||||||
| Total variable and Shield Level annuity sales | $2,263 | $2,225 | $2,105 | $2,122 | $2,069 | $8,715 | $8,300 | |||||||||||||||||||||||||||||||||||||
| FIXED AND INCOME ANNUITY SALES | ||||||||||||||||||||||||||||||||||||||||||||
| Fixed index annuities (2) | $142 | $126 | $89 | $26 | $62 | $383 | $554 | |||||||||||||||||||||||||||||||||||||
| Fixed deferred annuities | 324 | 377 | 412 | 103 | 97 | 1,216 | 1,121 | |||||||||||||||||||||||||||||||||||||
| Single premium immediate annuities | 2 | 1 | 2 | 5 | 6 | 10 | 38 | |||||||||||||||||||||||||||||||||||||
| Other fixed and income annuities | 3 | 2 | 2 | 3 | 5 | 10 | 35 | |||||||||||||||||||||||||||||||||||||
| Total fixed and income annuity sales | $471 | $506 | $505 | $137 | $170 | $1,619 | $1,748 | |||||||||||||||||||||||||||||||||||||
| (1) Shield Level Annuities refers to our suite of structured annuities consisting of products marketed under various names. | ||||||||||||||||||||||||||||||||||||||||||||
| (2) Represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | 10 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| Adjusted revenues | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Premiums | $101 | $102 | $104 | $121 | $126 | $428 | $480 | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 83 | 74 | 78 | 59 | 62 | 294 | 174 | |||||||||||||||||||||||||||||||||||||
| Net investment income | 111 | 117 | 97 | 107 | 126 | 432 | 466 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 3 | 4 | 4 | 4 | 4 | 15 | 15 | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $298 | $297 | $283 | $291 | $318 | $1,169 | $1,135 | |||||||||||||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $182 | $142 | $213 | $187 | $158 | $724 | $710 | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 30 | 30 | 28 | 27 | 29 | 115 | 105 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | 21 | 22 | 22 | 22 | 23 | 87 | 94 | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Other operating costs | 46 | 54 | 53 | 45 | 44 | 198 | 188 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | 279 | 248 | 316 | 281 | 254 | 1,124 | 1,097 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | 19 | 49 | (33) | 10 | 64 | 45 | 38 | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | 1 | 9 | (7) | 1 | 12 | 4 | 5 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | $18 | $40 | $(26) | $9 | $52 | $41 | $33 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 11 | |||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| LIFE ACCOUNT VALUE: GENERAL ACCOUNT | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Universal and variable universal life account value, beginning of period | $2,615 | $2,605 | $2,597 | $2,590 | $2,579 | |||||||||||||||||||||||||||
| Premiums and deposits (1) | 66 | 65 | 62 | 69 | 67 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (38) | (36) | (41) | (46) | (31) | |||||||||||||||||||||||||||
| Net flows | 28 | 29 | 21 | 23 | 36 | |||||||||||||||||||||||||||
| Net transfers from (to) separate account | 10 | 12 | 8 | 10 | 9 | |||||||||||||||||||||||||||
| Interest credited | 29 | 29 | 26 | 27 | 28 | |||||||||||||||||||||||||||
| Policy charges and other | (55) | (60) | (47) | (53) | (62) | |||||||||||||||||||||||||||
| Universal and variable universal life account value, end of period | $2,627 | $2,615 | $2,605 | $2,597 | $2,590 | |||||||||||||||||||||||||||
| LIFE ACCOUNT VALUE: SEPARATE ACCOUNT | ||||||||||||||||||||||||||||||||
| Variable universal life account value, beginning of period | $6,859 | $6,632 | $6,125 | $6,419 | $6,511 | |||||||||||||||||||||||||||
| Premiums and deposits | 35 | 34 | 36 | 38 | 37 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (83) | (89) | (71) | (92) | (73) | |||||||||||||||||||||||||||
| Net flows | (48) | (55) | (35) | (54) | (36) | |||||||||||||||||||||||||||
| Investment performance | 118 | 341 | 605 | (180) | 10 | |||||||||||||||||||||||||||
| Net transfers from (to) general account | (10) | (12) | (8) | (10) | (9) | |||||||||||||||||||||||||||
| Policy charges and other | (59) | (47) | (55) | (50) | (57) | |||||||||||||||||||||||||||
| Variable universal life account value, end of period | $6,860 | $6,859 | $6,632 | $6,125 | $6,419 | |||||||||||||||||||||||||||
| (1) Includes premiums and deposits directed to the general account investment option of variable products. | ||||||||||||||||||||||||||||||||

| Financial Supplement | 12 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| LIFE SALES | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Total life sales | $36 | $38 | $33 | $36 | $33 | $143 | $120 | |||||||||||||||||||||||||||||||||||||
| As of | ||||||||||||||||||||||||||||||||
| LIFE INSURANCE IN-FORCE | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Whole Life | ||||||||||||||||||||||||||||||||
| Life Insurance in-force, before reinsurance | $16,098 | $16,280 | $16,441 | $16,666 | $16,904 | |||||||||||||||||||||||||||
| Life Insurance in-force, net of reinsurance | $2,761 | $2,799 | $2,818 | $2,855 | $2,932 | |||||||||||||||||||||||||||
| Term Life | ||||||||||||||||||||||||||||||||
| Life Insurance in-force, before reinsurance | $312,477 | $319,061 | $325,210 | $331,301 | $337,199 | |||||||||||||||||||||||||||
| Life Insurance in-force, net of reinsurance | $258,169 | $263,178 | $267,845 | $272,711 | $277,203 | |||||||||||||||||||||||||||
| Universal and Variable Universal Life | ||||||||||||||||||||||||||||||||
| Life Insurance in-force, before reinsurance | $41,053 | $41,500 | $41,726 | $41,735 | $42,399 | |||||||||||||||||||||||||||
| Life Insurance in-force, net of reinsurance | $31,603 | $31,915 | $32,026 | $31,926 | $32,459 | |||||||||||||||||||||||||||

| Financial Supplement | 13 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| Adjusted revenues | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Premiums | $— | $— | $2 | $— | $— | $2 | $1 | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | 87 | 85 | 90 | 88 | 98 | 350 | 331 | |||||||||||||||||||||||||||||||||||||
| Net investment income | 305 | 292 | 283 | 272 | 328 | 1,152 | 1,234 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 6 | 8 | 7 | 7 | 7 | 28 | 29 | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $398 | $385 | $382 | $367 | $433 | $1,532 | $1,595 | |||||||||||||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $392 | $(519) | $400 | $352 | $367 | $625 | $1,105 | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 56 | 61 | 58 | 60 | 61 | 235 | 243 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Other operating costs | 31 | 32 | 29 | 36 | 39 | 128 | 166 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | 479 | (426) | 487 | 448 | 467 | 988 | 1,514 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) before provision for income tax | (81) | 811 | (105) | (81) | (34) | 544 | 81 | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | (23) | 170 | (22) | (17) | (7) | 108 | 16 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | $(58) | $641 | $(83) | $(64) | $(27) | $436 | $65 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 14 | |||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| UNIVERSAL LIFE WITH SECONDARY GUARANTEES ACCOUNT VALUE | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Account value, beginning of period | $4,548 | $4,619 | $4,710 | $4,779 | $4,848 | |||||||||||||||||||||||||||
| Premiums and deposits (1) | 145 | 146 | 156 | 157 | 158 | |||||||||||||||||||||||||||
| Withdrawals, surrenders and contract benefits | (34) | (20) | (42) | (20) | (25) | |||||||||||||||||||||||||||
| Net flows | 111 | 126 | 114 | 137 | 133 | |||||||||||||||||||||||||||
| Interest credited | 39 | 39 | 39 | 40 | 42 | |||||||||||||||||||||||||||
| Policy charges and other | (237) | (236) | (244) | (246) | (244) | |||||||||||||||||||||||||||
| Account value, end of period | $4,461 | $4,548 | $4,619 | $4,710 | $4,779 | |||||||||||||||||||||||||||
| As of | ||||||||||||||||||||||||||||||||
| LIFE INSURANCE IN-FORCE | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Universal Life with Secondary Guarantees | ||||||||||||||||||||||||||||||||
| Life Insurance in-force, before reinsurance | $66,293 | $66,904 | $67,445 | $68,039 | $68,528 | |||||||||||||||||||||||||||
| Life Insurance in-force, net of reinsurance | $32,190 | $32,556 | $32,879 | $33,212 | $33,537 | |||||||||||||||||||||||||||
| (1) Includes premiums and deposits directed to the general account investment option of variable products. | ||||||||||||||||||||||||||||||||

| Financial Supplement | 15 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| Adjusted revenues | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Premiums | $— | $— | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||||||
| Universal life and investment-type product policy fees | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Net investment income | 142 | 148 | 155 | 159 | 170 | 604 | 694 | |||||||||||||||||||||||||||||||||||||
| Other revenues | 2 | 5 | 3 | (5) | 2 | 5 | 12 | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $144 | $153 | $158 | $154 | $172 | $609 | $706 | |||||||||||||||||||||||||||||||||||||
| Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
| Policyholder benefits and claims | $— | $— | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||||||
| Interest credited to policyholder account balances | 97 | 103 | 103 | 106 | 114 | 409 | 450 | |||||||||||||||||||||||||||||||||||||
| Amortization of DAC and VOBA | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Interest expense on debt | 38 | 38 | 38 | 38 | 38 | 152 | 152 | |||||||||||||||||||||||||||||||||||||
| Other operating costs | 44 | 8 | 20 | 11 | (1) | 83 | 41 | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | 179 | 149 | 161 | 155 | 151 | 644 | 643 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings before provision for income tax | (35) | 4 | (3) | (1) | 21 | (35) | 63 | |||||||||||||||||||||||||||||||||||||
| Provision for income tax expense (benefit) | (11) | (9) | (3) | (5) | (5) | (28) | (14) | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) after provision for income tax | (24) | 13 | — | 4 | 26 | (7) | 77 | |||||||||||||||||||||||||||||||||||||
| Less: Net income (loss) attributable to noncontrolling interests | 1 | 2 | — | 2 | 1 | 5 | 5 | |||||||||||||||||||||||||||||||||||||
| Less: Preferred stock dividends | 25 | 26 | 25 | 26 | 25 | 102 | 102 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | $(50) | $(15) | $(25) | $(24) | $— | $(114) | $(30) | |||||||||||||||||||||||||||||||||||||
INSTITUTIONAL SPREAD MARGIN BUSINESS ACCOUNT BALANCE | ||||||||||||||||||||||||||||||||||||||||||||
Institutional spread margin business account balance, end of period | $9,477 | $9,850 | $10,149 | $10,092 | $10,976 | |||||||||||||||||||||||||||||||||||||||


| Financial Supplement | 17 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| CHANGE IN MARKET RISK BENEFITS | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Market risk benefits mark-to-market | $205 | $(424) | $1,020 | $(999) | $1,323 | $(198) | $2,103 | |||||||||||||||||||||||||||||||||||||
| Market risk benefits fees, net of claims | 151 | 136 | 97 | 95 | 180 | 479 | 603 | |||||||||||||||||||||||||||||||||||||
| Ceded reinsurance | (7) | (1) | (16) | 11 | (16) | (13) | (33) | |||||||||||||||||||||||||||||||||||||
| Total change in market risk benefits | $349 | $(289) | $1,101 | $(893) | $1,487 | $268 | $2,673 | |||||||||||||||||||||||||||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| NET DERIVATIVE GAINS (LOSSES) | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Net derivative gains (losses): | ||||||||||||||||||||||||||||||||||||||||||||
| Variable annuity and Shield hedges | $(12) | $1,310 | $1,073 | $(877) | $(379) | $1,494 | $660 | |||||||||||||||||||||||||||||||||||||
| Shield embedded derivatives | (354) | (1,694) | (2,103) | 1,171 | (286) | (2,980) | (3,776) | |||||||||||||||||||||||||||||||||||||
| ULSG hedges | (69) | (10) | (154) | 22 | (361) | (211) | (557) | |||||||||||||||||||||||||||||||||||||
| Other hedges and embedded derivatives | (20) | (16) | (54) | (5) | 31 | (95) | (26) | |||||||||||||||||||||||||||||||||||||
| Subtotal | (455) | (410) | (1,238) | 311 | (995) | (1,792) | (3,699) | |||||||||||||||||||||||||||||||||||||
| Investment hedge adjustments | (1) | — | 1 | — | 3 | — | 31 | |||||||||||||||||||||||||||||||||||||
| Total net derivative gains (losses) | $(456) | $(410) | $(1,237) | $311 | $(992) | $(1,792) | $(3,668) | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | 18 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Actuarial items and other insurance adjustments | $13 | $(709) | $— | $10 | $48 | $(686) | $(110) | |||||||||||||||||||||||||||||||||||||
| Total notable items (1) | $13 | $(709) | $— | $10 | $48 | $(686) | $(110) | |||||||||||||||||||||||||||||||||||||
| NOTABLE ITEMS BY SEGMENT | ||||||||||||||||||||||||||||||||||||||||||||
| Annuities | $— | $7 | $— | $10 | $48 | $17 | $28 | |||||||||||||||||||||||||||||||||||||
| Life | 6 | (11) | — | — | — | (5) | 139 | |||||||||||||||||||||||||||||||||||||
| Run-off | 7 | (705) | — | — | — | (698) | (277) | |||||||||||||||||||||||||||||||||||||
| Corporate & Other | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Total notable items (1) | $13 | $(709) | $— | $10 | $48 | $(686) | $(110) | |||||||||||||||||||||||||||||||||||||
| (1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | 19 | |||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| VARIABLE ANNUITY SEPARATE ACCOUNT RETURNS | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Total Quarterly VA separate account gross returns | 2.14% | 4.96% | 7.59% | (0.54)% | (1.23)% | |||||||||||||||||||||||||||
| TOTAL VARIABLE ANNUITY SEPARATE ACCOUNT ALLOCATIONS | ||||||||||||||||||||||||||||||||
| Percent allocated to equity funds | 32.56% | 32.61% | 32.54% | 31.28% | 32.36% | |||||||||||||||||||||||||||
| Percent allocated to bond funds/other funds | 9.20% | 9.13% | 9.04% | 9.58% | 9.21% | |||||||||||||||||||||||||||
| Percent allocated to target volatility funds | 17.77% | 17.85% | 17.81% | 18.41% | 18.03% | |||||||||||||||||||||||||||
| Percent allocated to balanced funds | 40.47% | 40.41% | 40.61% | 40.73% | 40.40% | |||||||||||||||||||||||||||

| Financial Supplement | 20 | |||||||||||||
| December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||
| Amount | % of Total | Amount | % of Total | |||||||||||||||||||||||
| Fixed maturity securities: | ||||||||||||||||||||||||||
| U.S. corporate securities | $38,909 | 30.88% | $37,123 | 30.32% | ||||||||||||||||||||||
| Foreign corporate securities | 11,497 | 9.12% | 11,830 | 9.66% | ||||||||||||||||||||||
| Residential mortgage-backed securities | 8,532 | 6.77% | 7,287 | 5.95% | ||||||||||||||||||||||
| U.S. government and agency securities | 6,711 | 5.32% | 6,747 | 5.51% | ||||||||||||||||||||||
| Asset-backed securities | 6,059 | 4.81% | 6,312 | 5.16% | ||||||||||||||||||||||
| Commercial mortgage-backed securities | 5,870 | 4.66% | 6,356 | 5.19% | ||||||||||||||||||||||
| State and political subdivision securities | 3,494 | 2.77% | 3,441 | 2.81% | ||||||||||||||||||||||
| Foreign government securities | 942 | 0.75% | 959 | 0.79% | ||||||||||||||||||||||
| Total fixed maturity securities | 82,014 | 65.08% | 80,055 | 65.39% | ||||||||||||||||||||||
| Trading securities | 506 | 0.40% | — | 0.00% | ||||||||||||||||||||||
| Equity securities | 79 | 0.06% | 77 | 0.06% | ||||||||||||||||||||||
| Mortgage loans: | ||||||||||||||||||||||||||
| Commercial mortgage loans | 12,323 | 9.78% | 13,330 | 10.89% | ||||||||||||||||||||||
| Residential mortgage loans | 5,976 | 4.74% | 5,543 | 4.53% | ||||||||||||||||||||||
| Agricultural mortgage loans | 4,656 | 3.70% | 4,591 | 3.75% | ||||||||||||||||||||||
| Allowance for credit losses | (200) | (0.16)% | (178) | (0.15)% | ||||||||||||||||||||||
| Total mortgage loans, net | 22,755 | 18.06% | 23,286 | 19.02% | ||||||||||||||||||||||
| Policy loans | 1,450 | 1.15% | 2,024 | 1.65% | ||||||||||||||||||||||
| Limited partnerships and limited liability companies | 4,696 | 3.73% | 4,827 | 3.94% | ||||||||||||||||||||||
| Cash, cash equivalents and short-term investments | 6,584 | 5.22% | 6,913 | 5.65% | ||||||||||||||||||||||
| Other invested assets: | ||||||||||||||||||||||||||
| Derivatives: | ||||||||||||||||||||||||||
| Equity market | 6,121 | 4.86% | 3,265 | 2.67% | ||||||||||||||||||||||
| Interest rate | 297 | 0.23% | 287 | 0.23% | ||||||||||||||||||||||
| Foreign currency exchange rate | 350 | 0.28% | 564 | 0.46% | ||||||||||||||||||||||
| Credit | 11 | 0.01% | 19 | 0.02% | ||||||||||||||||||||||
| Total derivatives | 6,779 | 5.38% | 4,135 | 3.38% | ||||||||||||||||||||||
| ICOLI | 822 | 0.65% | 772 | 0.63% | ||||||||||||||||||||||
| FHLB common stock | 217 | 0.17% | 222 | 0.18% | ||||||||||||||||||||||
| Other | 114 | 0.10% | 121 | 0.10% | ||||||||||||||||||||||
| Total other invested assets | 7,932 | 6.30% | 5,250 | 4.29% | ||||||||||||||||||||||
| Total investments and cash and cash equivalents | $126,016 | 100.00% | $122,432 | 100.00% | ||||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||
Adjusted net investment income yield (1) | 4.44% | 4.40% | 4.28% | 4.25% | 4.51% | |||||||||||||||||||||||||||
| (1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||

| Financial Supplement | 21 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| COMBINED REVENUES AND EXPENSES (1) | PRELIMINARY December 31, 2025 (2) | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | PRELIMINARY December 31, 2025 (2) | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Total revenues (Line 9) | $3,000 | $2,293 | $1,455 | $4,809 | $3,175 | $11,557 | $11,813 | |||||||||||||||||||||||||||||||||||||
Total benefits and expenses before dividends to policyholders (Line 28) | $2,900 | $3,679 | $2,360 | $3,584 | $3,219 | $12,523 | $13,170 | |||||||||||||||||||||||||||||||||||||
| COMBINED NET INCOME (LOSS) (1) | ||||||||||||||||||||||||||||||||||||||||||||
Gain (loss) from operations net of taxes and dividends to policyholders (Line 33) | $100 | $(1,333) | $(921) | $1,225 | $(40) | $(929) | $(1,356) | |||||||||||||||||||||||||||||||||||||
Net realized capital gains (losses), net of taxes and certain transfers to interest maintenance reserve (Line 34) | (400) | 599 | (643) | (784) | 455 | (1,228) | 514 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) (Line 35) | $(300) | $(734) | $(1,564) | $441 | $415 | $(2,157) | $(842) | |||||||||||||||||||||||||||||||||||||
| For the Year Ended | ||||||||||||||||||||||||||||||||||||||||||||
| NORMALIZED STATUTORY EARNINGS (LOSS) (3), (4) | PRELIMINARY December 31, 2025 (2) | December 31, 2024 | ||||||||||||||||||||||||||||||||||||||||||
| (In billions) | ||||||||||||||||||||||||||||||||||||||||||||
Statutory net gain (loss) from operations, pre-tax | $(1.1) | $(1.2) | ||||||||||||||||||||||||||||||||||||||||||
| Add: net realized capital gains (losses) | (1.2) | 0.5 | ||||||||||||||||||||||||||||||||||||||||||
Add: change in total asset requirement at CTE98, net of the change in VA reserves | 1.6 | (1.3) | ||||||||||||||||||||||||||||||||||||||||||
Add: unrealized gains (losses) on VA & Shield hedges, net of reinsurance, and other equity risk management strategies | 2.0 | (0.1) | ||||||||||||||||||||||||||||||||||||||||||
Add: impact of actuarial items and other adjustments | (0.3) | 0.8 | ||||||||||||||||||||||||||||||||||||||||||
| Normalized statutory earnings (loss) | $1.0 | $(1.3) | ||||||||||||||||||||||||||||||||||||||||||
| (1) Combined statutory results are for Brighthouse Life Insurance Company, Brighthouse Life Insurance Company of NY and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results for the three months and year ended December 31, 2025. | ||||||||||||||||||||||||||||||||||||||||||||
| (3) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||
| (4) Normalized statutory earnings (loss), presented in billions, is for Brighthouse Life Insurance Company and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | 22 | |||||||||||||
| As of | ||||||||||||||||||||||||||||||||||||||
| COMBINED ASSETS, LIABILITIES, AND CAPITAL AND SURPLUS (1) | PRELIMINARY December 31, 2025 (2) | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 (3) | |||||||||||||||||||||||||||||||||
Total assets (Line 28) | $201,000 | $203,382 | $202,943 | $193,978 | $198,370 | |||||||||||||||||||||||||||||||||
| Total liabilities (Line 28) | $197,100 | $199,492 | $198,900 | $189,859 | $194,491 | |||||||||||||||||||||||||||||||||
Total capital and surplus (Line 38) | $3,900 | $3,890 | $4,043 | $4,119 | $3,879 | |||||||||||||||||||||||||||||||||
COMBINED TAC AND RBC RATIO (1), (4) | ||||||||||||||||||||||||||||||||||||||
Combined total adjusted capital | $5,300 | $5,400 | $5,560 | $5,549 | $5,373 | |||||||||||||||||||||||||||||||||
Combined risk-based capital ratio (5) | 456% | 435%-455% | 405%-425% | 420%-440% | 402% | |||||||||||||||||||||||||||||||||
DIVIDENDS PAID TO HOLDING COMPANY (1), (4) | ||||||||||||||||||||||||||||||||||||||
| Total dividends paid | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||
| (1) Combined statutory results are for Brighthouse Life Insurance Company and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results as of December 31, 2025. | ||||||||||||||||||||||||||||||||||||||
(3) Includes a $100 million capital contribution to Brighthouse Life Insurance Company made subsequent to December 31, 2024. | ||||||||||||||||||||||||||||||||||||||
(4) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||
(5) The RBC ratio is reported as a preliminary range for all periods, except those ended December 31. | ||||||||||||||||||||||||||||||||||||||


| Financial Supplement | A-1 | |||||||||||||

| Financial Supplement | A-2 | |||||||||||||
| Non-GAAP financial measures: | Most directly comparable GAAP financial measures: | |||||||||||||
| (i) | adjusted earnings | (i) | net income (loss) available to shareholders (1) | |||||||||||
| (ii) | adjusted earnings, less notable items | (ii) | net income (loss) available to shareholders (1) | |||||||||||
| (iii) | adjusted revenues | (iii) | revenues | |||||||||||
| (iv) | adjusted expenses | (iv) | expenses | |||||||||||
| (v) | adjusted earnings per common share | (v) | earnings per common share, diluted (1) | |||||||||||
| (vi) | adjusted earnings per common share, less notable items | (vi) | earnings per common share, diluted (1) | |||||||||||
| (vii) | adjusted return on common equity | (vii) | return on common equity (2) | |||||||||||
| (viii) | adjusted return on common equity, less notable items | (viii) | return on common equity (2) | |||||||||||
| (ix) | adjusted net investment income | (ix) | net investment income | |||||||||||
(x) | adjusted net investment income yield | (x) | net investment income yield | |||||||||||
| __________________ | ||||||||||||||
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.’s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share. | ||||||||||||||
(2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.’s common stockholders' equity. | ||||||||||||||

| Financial Supplement | A-3 | |||||||||||||

| Financial Supplement | A-4 | |||||||||||||

| Financial Supplement | A-5 | |||||||||||||

| Financial Supplement | A-6 | |||||||||||||
| AOCI | Accumulated other comprehensive income (loss) | ||||
| CTE | Conditional tail expectations | ||||
| DAC | Deferred policy acquisition costs | ||||
| FHLB | Federal Home Loan Bank | ||||
| GAAP | Accounting principles generally accepted in the United States of America | ||||
| GMDB | Guaranteed minimum death benefits | ||||
| GMIB | Guaranteed minimum income benefits | ||||
| GMWB | Guaranteed minimum withdrawal benefits | ||||
| ICOLI | Insurance company-owned life insurance | ||||
| NDGL | Net derivative gains (losses) | ||||
| NIGL | Net investment gains (losses) | ||||
| RBC | Risk-based capital | ||||
| TAC | Total adjusted capital | ||||
| ULSG | Universal life insurance with secondary guarantees | ||||
| VA | Variable annuity | ||||
| VOBA | Value of business acquired | ||||

| Financial Supplement | A-7 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| ADJUSTED EARNINGS, LESS NOTABLE ITEMS (1) | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders | $112 | $453 | $60 | $(294) | $646 | $331 | $286 | |||||||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (23) | 48 | (39) | (83) | (73) | (97) | (295) | |||||||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (7) | 7 | (6) | 6 | — | — | — | |||||||||||||||||||||||||||||||||||||
| Less: Net derivative gains (losses), excluding investment hedge adjustments | (455) | (410) | (1,238) | 311 | (995) | (1,792) | (3,699) | |||||||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | 349 | (289) | 1,101 | (893) | 1,487 | 268 | 2,673 | |||||||||||||||||||||||||||||||||||||
| Less: Market value adjustments | 6 | (10) | 6 | (10) | 14 | (8) | 13 | |||||||||||||||||||||||||||||||||||||
| Less: Provision for income tax (expense) benefit on reconciling adjustments | 28 | 137 | 38 | 140 | (91) | 343 | 275 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) | 214 | 970 | 198 | 235 | 304 | 1,617 | 1,319 | |||||||||||||||||||||||||||||||||||||
| Less: Notable items | (13) | 709 | — | (10) | (48) | 686 | 110 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items | $227 | $261 | $198 | $245 | $352 | $931 | $1,209 | |||||||||||||||||||||||||||||||||||||
| ADJUSTED EARNINGS, LESS NOTABLE ITEMS PER COMMON SHARE (1), (2) | ||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) available to shareholders per common share | $1.93 | $7.89 | $1.02 | $(5.04) | $10.79 | $5.71 | $4.64 | |||||||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (0.40) | 0.83 | (0.68) | (1.42) | (1.22) | (1.67) | (4.79) | |||||||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (0.12) | 0.12 | (0.10) | 0.10 | — | — | — | |||||||||||||||||||||||||||||||||||||
| Less: Net derivative gains (losses), excluding investment hedge adjustments | (7.87) | (7.13) | (21.44) | 5.34 | (16.63) | (30.93) | (60.05) | |||||||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | 6.04 | (5.02) | 19.07 | (15.33) | 24.86 | 4.63 | 43.39 | |||||||||||||||||||||||||||||||||||||
| Less: Market value adjustments | 0.10 | (0.17) | 0.10 | (0.17) | 0.23 | (0.14) | 0.21 | |||||||||||||||||||||||||||||||||||||
| Less: Provision for income tax (expense) benefit on reconciling adjustments | 0.48 | 2.38 | 0.66 | 2.40 | (1.52) | 5.92 | 4.46 | |||||||||||||||||||||||||||||||||||||
| Less: Impact of inclusion of dilutive shares | — | — | — | 0.03 | — | — | — | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings (loss) per common share | 3.70 | 16.87 | 3.43 | 4.01 | 5.07 | 27.92 | 21.40 | |||||||||||||||||||||||||||||||||||||
Less: Notable items | (0.22) | 12.33 | — | (0.17) | (0.80) | 11.84 | 1.79 | |||||||||||||||||||||||||||||||||||||
| Adjusted earnings, less notable items per common share | $3.93 | $4.54 | $3.43 | $4.17 | $5.88 | $16.07 | $19.63 | |||||||||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in this Appendix. | ||||||||||||||||||||||||||||||||||||||||||||
| (2) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. | ||||||||||||||||||||||||||||||||||||||||||||

| Financial Supplement | A-8 | |||||||||||||
| Four Quarters Cumulative Trailing Basis | ||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Net income (loss) available to shareholders | $331 | $865 | $562 | $511 | $286 | |||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (97) | (147) | (255) | (336) | (295) | |||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | — | 7 | — | 6 | — | |||||||||||||||||||||||||||
| Less: Net derivative gains (losses), excluding investment hedge adjustments | (1,792) | (2,332) | (2,021) | (1,454) | (3,699) | |||||||||||||||||||||||||||
| Less: Change in market risk benefits | 268 | 1,406 | 1,085 | 340 | 2,673 | |||||||||||||||||||||||||||
| Less: Market value adjustments | (8) | — | (1) | (1) | 13 | |||||||||||||||||||||||||||
| Less: Provision for income tax (expense) benefit on reconciling adjustments | 343 | 224 | 250 | 304 | 275 | |||||||||||||||||||||||||||
| Adjusted earnings | $1,617 | $1,707 | $1,504 | $1,652 | $1,319 | |||||||||||||||||||||||||||
| Five Quarters Average Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
BRIGHTHOUSE FINANCIAL, INC.’S COMMON STOCKHOLDERS’ EQUITY, EXCLUDING AOCI | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s stockholders’ equity | $5,800 | $5,552 | $5,107 | $4,812 | $4,753 | |||||||||||||||||||||||||||
| Less: Preferred stock, net | 1,699 | 1,699 | 1,699 | 1,699 | 1,699 | |||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s common stockholders’ equity | 4,101 | 3,853 | 3,408 | 3,113 | 3,054 | |||||||||||||||||||||||||||
| Less: AOCI | (4,391) | (4,470) | (4,750) | (4,981) | (5,097) | |||||||||||||||||||||||||||
| Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $8,492 | $8,323 | $8,158 | $8,094 | $8,151 | |||||||||||||||||||||||||||
| Five Quarters Average Common Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
ADJUSTED RETURN ON COMMON EQUITY, EXCLUDING AOCI | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Return on common equity | 8.1% | 22.5% | 16.5% | 16.4% | 9.4% | |||||||||||||||||||||||||||
| Return on AOCI | (7.5)% | (19.4)% | (11.8)% | (10.3)% | (5.6)% | |||||||||||||||||||||||||||
| Return on common equity, excluding AOCI | 3.9% | 10.4% | 6.9% | 6.3% | 3.5% | |||||||||||||||||||||||||||
| Less: Return on net investment gains (losses) | (1.1)% | (1.8)% | (3.1)% | (4.2)% | (3.6)% | |||||||||||||||||||||||||||
| Less: Return on investment gains (losses) on trading securities | —% | 0.1% | —% | 0.1% | —% | |||||||||||||||||||||||||||
| Less: Return on net derivative gains (losses), excluding investment hedge adjustments | (21.1)% | (28.0)% | (24.8)% | (18.0)% | (45.4)% | |||||||||||||||||||||||||||
| Less: Return on change in market risk benefits | 3.2% | 16.9% | 13.3% | 4.2% | 32.8% | |||||||||||||||||||||||||||
| Less: Return on market value adjustments | (0.1)% | —% | —% | —% | 0.2% | |||||||||||||||||||||||||||
| Less: Return on provision for income tax (expense) benefit on reconciling adjustments | 4.0% | 2.7% | 3.1% | 3.8% | 3.3% | |||||||||||||||||||||||||||
| Adjusted return on common equity, excluding AOCI | 19.0% | 20.5% | 18.4% | 20.4% | 16.2% | |||||||||||||||||||||||||||

| Financial Supplement | A-9 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | ||||||||||||||||||||||||||||||||||||||
| Total revenues | $1,689 | $1,816 | $871 | $2,390 | $1,205 | $6,766 | $4,724 | |||||||||||||||||||||||||||||||||||||
| Less: Net investment gains (losses) | (23) | 48 | (39) | (83) | (73) | (97) | (295) | |||||||||||||||||||||||||||||||||||||
| Less: Investment gains (losses) on trading securities | (7) | 7 | (6) | 6 | — | — | — | |||||||||||||||||||||||||||||||||||||
| Less: Net derivative gains (losses) | (456) | (410) | (1,237) | 311 | (992) | (1,792) | (3,668) | |||||||||||||||||||||||||||||||||||||
| Less: Investment hedge adjustments | 1 | — | (1) | — | (3) | — | (31) | |||||||||||||||||||||||||||||||||||||
| Total adjusted revenues | $2,174 | $2,171 | $2,154 | $2,156 | $2,273 | $8,655 | $8,718 | |||||||||||||||||||||||||||||||||||||
| Total expenses | $1,539 | $1,231 | $778 | $2,744 | $371 | $6,292 | $4,302 | |||||||||||||||||||||||||||||||||||||
| Less: Change in market risk benefits | (349) | 289 | (1,101) | 893 | (1,487) | (268) | (2,673) | |||||||||||||||||||||||||||||||||||||
| Less: Market value adjustments | (6) | 10 | (6) | 10 | (14) | 8 | (13) | |||||||||||||||||||||||||||||||||||||
| Total adjusted expenses | $1,894 | $932 | $1,885 | $1,841 | $1,872 | $6,552 | $6,988 | |||||||||||||||||||||||||||||||||||||

| Financial Supplement | A-10 | |||||||||||||
| For the Three Months Ended | For the Year Ended | |||||||||||||||||||||||||||||||||||||||||||
| NET INVESTMENT GAINS (LOSSES) | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | December 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||||||||||||
| Investment portfolio gains (losses) | $(14) | $52 | $(5) | $(31) | $(53) | $2 | $(182) | |||||||||||||||||||||||||||||||||||||
| Investment portfolio credit loss (provision) release and (writedowns) | (9) | (4) | (34) | (52) | (20) | (99) | (113) | |||||||||||||||||||||||||||||||||||||
| Net investment gains (losses) | $(23) | $48 | $(39) | $(83) | $(73) | $(97) | $(295) | |||||||||||||||||||||||||||||||||||||
| For the Three Months Ended | ||||||||||||||||||||||||||||||||
| ADJUSTED NET INVESTMENT INCOME YIELD (1) | December 31, 2025 | September 30, 2025 | June 30, 2025 | March 31, 2025 | December 31, 2024 | |||||||||||||||||||||||||||
| Investment income yield | 4.60% | 4.54% | 4.41% | 4.39% | 4.64% | |||||||||||||||||||||||||||
| Investment fees and expenses | (0.16)% | (0.14)% | (0.13)% | (0.14)% | (0.13)% | |||||||||||||||||||||||||||
| Adjusted net investment income yield | 4.44% | 4.40% | 4.28% | 4.25% | 4.51% | |||||||||||||||||||||||||||
| (1) See definitions for Non-GAAP and Other Financial Disclosures in this Appendix. | ||||||||||||||||||||||||||||||||

